Cardiovascular Diseases

818 trials 341 recruiting

Filter these 818 trials by phase, country and sponsor.

Open in Search →

A Randomized Study in Healthy Participants to Identify the Optimal Subcutaneous Injection Strategy for COR-1167 Pending

2026-526096-31-00 Chronic Heart Failure 3
Randomized, open-label, multiple dose, two-period, two-treatment, cross-over pharmacodynamic study in healthy male and female participants u… Pending

2026-526556-31-00 Pharmacodynamic study under fasting condition. 3
Stabilization of vulnerable atherosclerotic carotid plaques by Rivaroxaban as evaluated by 3D contrast enhanced ultrasound (CEUS) Pending

2024-518539-13-00 Patients with - Stable peripheral artery disease and - 11
Prevention of heart disease in heart-healthy patients with diabetes based on a special parameter (NT-proBNP) Pending

2024-519051-28-01 Diabetes mellitus Type 2 6
LEVOMEMS: Comparison of the effects of dobutamine and levosimendan in the current treatment of heart diseases. Pending

2024-519631-42-00 Heart failure patients with depressed left ventricular 11
A study to learn about how a new nurandociguat tablet is absorbed and processed in the body compared to an old tablet and how food affects t… Pending

2025-524176-36-00 Chronic Kidney Disease 3
Waiting on Atrial fibrillation Intervention Therapy (WAIT) Study Pending

2025-524182-25-00 Atrial fibrillation 6
Pulse corticosteroids or/and Immunoglobulins to treat fulminant Myocarditis: a double-blind randomized controlled adaptive trial (The CORIUM… Pending

2023-506599-28-01 Fulminant myocarditis 4
MAMI Use of the Methoxyflurane as pain-killer in the prehospital management of Acute Myocardial Infarction Pending

2025-523349-86-00 Acute Myocardial Infarction 5
RATE: Reduced anticoagulation targets in extracorporeal life support Pending

2023-509675-16-01 All patients who receive ECMO treatment during the stud 5
CARotid plaqUe StabilizatiOn and regression with evolocumab Pending

2024-518566-27-00 carotid stenosis 6
Phase 1b Study of VERVE-201 in Patients with Refractory Hyperlipidemia Pending

2025-522617-39-00 Refractory hyperlipidemia 1
A randomized, placebo-controlled, double-blind, single-ascending-dose, Phase 1a/b study to assess the safety, pharmacokinetics, pharmacodyna… Pending

2024-512196-12-00 Acute Ischemic Stroke 1
ASPIRIN - Acetylsalicylic acid versus placebo in addition to a local non-steroidal anti-inflammatory drug in the treatment of thrombotic epi… Pending

2024-517595-38-00 Thrombotic episodes in superficial venous malformations 5
CARDIOPROTECTIVE-NEPHROPROTECTIVE EFFECTS OF SEVOFLURANE IN COMPARISON WITH PROPOFOL IN DOUBLE VALVE SURGERY. USE OF SEVOFLURANE AS A PILLAR… Pending

2025-520812-33-00 To evaluate the effects of sevoflurane administration i 10
Sodium-glucose cotransporter-2 inhibitors to stabilize coronary ather-osclerosis progression after acute myocardial infarction in women and … Pending

2025-523375-29-00 Myocardial Infarction 5
Randomized controlled trial evaluating the impact of mineralocorticoid receptor blockade by eplerenone on echocardiographic abnormalities am… Pending

2024-515860-29-00 kidney transplantation 5
MidregiOnal proatrial natriuretic peptide to guide SEcondary Stroke prevention: The MOSES-study Pending

2024-517600-11-01 Acute ischemic stroke 5
An open-label extension (OLE) trial to evaluate long-term safety and tolerability of pelacarsen (TQJ230) Recruiting

2024-519870-38-00 Atherosclerotic cardiovascular disease (ASCVD) 5 2026-05-11
Pharmacological optimization in prevention in Heart Failure: A Sex-gap? Recruiting

2025-520660-18-00 Heart Failure 6 2026-05-08
Phase 2 Study of REGN13335 in Adult Participants with Pulmonary Arterial Hypertension (PAH) Recruiting

2024-514754-79-00 Pulmonary Arterial Hypertension (PAH) 4 2026-05-06
REPO-HYPER II Recruiting

2024-520231-33-00 Treatment-resistant hypertension 4 2026-05-04
A study to learn more about how safe finerenone is, when it is taken for a longer time with standard treatment, in children and young adults… Recruiting

2024-519830-22-00 Heart failure due to systemic left ventricular systolic 5 2026-04-27
A Study to Evaluate the Effect of Obicetrapib and Ezetimibe Fixed-Dose Combination (FDC) or Obicetrapib on LDL-C in Participants With Type 2… Recruiting

2025-521936-12-00 Adults with Type 2 Diabetes and/or Metabolic Syndrome 5 2026-04-24